The latest research from Fore Pharma, US Psoriasis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Psoriasis pipeline products, Psoriasis epidemiology, Psoriasis market valuations and forecast, Psoriasis products sales and competitive landscape in the US.
The research is classified into nine sections – Psoriasis overview including etiology, pathophysiology, and diagnosis, Psoriasis treatment options, Psoriasis pipeline products, Psoriasis market analysis comprising of Psoriasis epidemiology, key products marketed for Psoriasis, market valuations and forecast, products sales and market shares.
Research Scope: - Psoriasis Pipeline: Find out the products in clinical trials for the treatment of Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Psoriasis Epidemiology: Find out the number of patients diagnosed (prevalence) with Psoriasis in the US - Psoriasis Products: Identify key products marketed and prescribed for Psoriasis in the US, including trade name, molecule name, and company - Psoriasis Product Sales: Find out the sales revenues of Psoriasis products, both branded and generics, in the US - Psoriasis Market Valuations: Find out the market size for Psoriasis products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020 - Psoriasis Products Market Share: Find out the market shares for key Psoriasis products in the US
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Psoriasis market analysis and sales trends - Track competitor drugs sales and market share in the US Psoriasis market - Track competitive developments in Psoriasis market and present key issues and learnings - Synthesize insights for Psoriasis market and products to drive business performance - Answer key business questions about the Psoriasis market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Psoriasis products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment.The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyelitis optica, systemic...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
573 pages •
By Global Industry Analysts
• Oct 2020
Looking Beyond Today’s Challenges to Tomorrow’s Healthcare Needs. Genetic Testing to Reach $18.9 Billion as the Burden of Non-Communicable Diseases Grows Bigger
The global market for Genetic Testing is forecast to reach US$18.9 billion by the year 2027, trailing a post COVID-19 CAGR of 8.6% over the analysis period 2020 through 2027....
On the rebound: Medicare reimbursement caps for physical therapy may constrain revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged...
No air: Demand for industry services has declined as a result of the closure of nonessential businesses Abstract Air Duct Cleaning Services in the US Operators in this industry provide air duct cleaning services to buildings and dwellings. This includes the cleaning of heating and cooling system components. This...
Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies...
Abstract Technical Support & Help Desk Services Procurement in the US This report is intended to assist buyers of technical support and help desk services. Technical support and help desk service providers field questions and incoming calls from customers in need of assistance with product or service features....
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
278 pages •
By Global Industry Analysts
• Sep 2020
Global Anatomic Pathology Market to Reach $26.3 Billion by 2027
Amid the COVID-19 crisis, the global market for Anatomic Pathology estimated at US$18.7 Billion in the year 2020, is projected to reach a revised size of US$26.3 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Instruments, one of the segments...
Pathology
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.